<unk>  is a calcium-sensing receptor agonist that is FDA approved for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.   Common adverse reactions include blood calcium decreased, muscle spasms, diarrhea, nausea, vomiting, headache, hypocalcemia, and paresthesia.
Etelcalcetide
Drotrecogin alfa
Trenonacog alfa
Pasireotide
Fludroxycortide
Prothipendyl
Neostigmine methylsulfate
Procyclidine hydrochloride